Sector consensus United Therapeutics Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 15:37:05 2025-07-07 EDT			5-day change	1st Jan Change
288.86 ^USD	-1.91%		+0.59%	-18.08%

06-30	United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says	MT
06-30	UBS Adjusts Price Target on United Therapeutics to $385 From $410, Maintains Buy Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Average Target P.	Ecart obj. / dr	Nbr of analysts
UNITED THERAPEUTICS CORPORATION		US$380.17	+29.09%	13
ELI LILLY AND COMPANY		US$951.98	+21.94%	27
JOHNSON & JOHNSON		US$169.23	+8.47%	23
ABBVIE INC.		US$209.12	+10.48%	27
NOVO NORDISK A/S		DKK 645.23	+42.97%	22
ROCHE HOLDING AG		CHF 302.68	+16.41%	20
NOVARTIS AG	-	CHF 119.55	-3.35%	19
ASTRAZENECA PLC		GBX 183.34	+30.02%	20
MERCK & CO., INC.		US$101.79	+25.77%	24
AMGEN INC.		US$314.27	+5.37%	28
PFIZER, INC.		US$29.06	+14.48%	23
GILEAD SCIENCES, INC.		US$116.77	+4.49%	26
SANOFI		€113.34	+36.08%	23
VERTEX PHARMACEUTICALS INCORPORATED		US$499.87	+8.76%	28
BRISTOL-MYERS SQUIBB COMPANY		US$57.1	+21.69%	22
CHUGAI PHARMACEUTICAL CO., LTD.		JP¥8,353.57	+17.24%	14
GSK PLC		GBX 16.61	+18.22%	19
JIANGSU HENGRUI MEDICINE CO., LTD.		CN¥65.39	+22.78%	18
TAKEDA PHARMACEUTICAL COMPANY LIMITED		JP¥4,946.56	+11.41%	16
Average		925.03	+18.02%	22
Weighted average by Cap.		607.43	+18.06%	23